台股 » 個股 » 共信-KY » 籌碼相關 » 融資融券與借券

共信-KY

(6617)
可現股當沖
  • 股價
    128.5
  • 漲跌
    ▲1.5
  • 漲幅
    +1.18%
  • 成交量
    2,101
  • 產業
    上櫃 生技醫療類股
  • 44人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
共信-KY (6617) 融資融券與借券

股票投資新手教室: 一分鐘搞懂「融資融券」

共信-KY (6617) 融資融券與借券

共信-KY (6617) 近三十日融資融券與借券賣出
日期 融資 融券 資券互抵(張) 資券當沖(%) 券資比(%) 價格 比例 成交量
增加 餘額 使用率% 增加 餘額 使用率%
08/261151,5004.715180.06001.21279.96%1,675
08/251991,3854.349130.0460.260.94115.54.05%2,276
08/24441,1863.72-340.01000.341113.26%1,375
08/21571,1423.58670.02000.61107.52.87%1,635
08/20-41,0853.4010000.09104.59.77%299
08/1931,0893.4201010.390.0995.2-0.94%256
08/18-171,0863.41-41020.420.0996.1-2.44%481
08/1761,1033.46-550.02000.4598.5-2.48%451
08/1461,0973.441100.03000.91101-0.98%585
08/13141,0913.42590.0320.480.821020.00%420
08/12-151,0773.38-940.0110.130.37102-0.49%753
08/111231,0923.43-14130.0460.291.19102.5-2.84%2,092
08/103049693.0421270.0820.12.79105.59.55%1,965
08/07286652.09660.0220.130.996.39.93%1,519
08/0649637200000087.69.91%441
08/05-75881.8400000079.70.50%263
08/04-55951.8700000079.3-0.75%206
08/03156001.8800000079.95.13%451
07/31-65851.84-10010.30761.47%337
07/3025911.85010000.1774.9-5.07%362
07/29-75891.8501040.950.1778.9-3.19%423
07/28-205961.87010000.1781.5-3.09%242
07/2716161.93-210000.1684.1-1.98%453
07/24-156151.93-3830.0110.20.4985.8-4.35%512
07/23-256301.9833410.1380.826.5189.7-9.21%972
07/22486552.05780.03299.551.2298.8-4.08%304
07/2116071.90104919.70.161033.00%249
07/20206061.90105319.660.17100-5.21%270
07/17-585861.84-110328.650.17105.5-8.66%370
07/16646442.02120.0111216.620.31115.56.45%674
日期 融券 借券賣出 價格 比例 成交量
買進 賣出 增加 餘額 使用率% 賣出 還券 調整 增加 餘額
08/26050518@Limit20.060500-501,0621279.96%1,675
08/25090913@Limit20.0426150111,112115.54.05%2,276
08/24300-34@Limit20.014400441,1011113.26%1,375
08/2106067@Limit20.022626001,057107.52.87%1,635
08/2000001@Limit200260-261,057104.59.77%299
08/1900001@Limit20340-11,08395.2-0.94%256
08/18400-41@Limit2050051,08496.1-2.44%481
08/17500-55@Limit20.022011091,07998.5-2.48%451
08/14010110@Limit20.032019011,070101-0.98%585
08/1305059@Limit20.0371061,0691020.00%420
08/121010-94@Limit20.0131021,063102-0.49%753
08/112060-1413@Limit20.042520231,061102.5-2.84%2,092
08/1012202127@Limit20.088500851,038105.59.55%1,965
08/0706066@Limit20.021185011395396.39.93%1,519
08/0600000@Limit2015240-984087.69.91%441
08/0500000@Limit2013130084979.70.50%263
08/0400000@Limit20350-284979.3-0.75%206
08/0300000@Limit2030202885179.95.13%451
07/31001-10@Limit2013370-24823761.47%337
07/3000001@Limit2015120384774.9-5.07%362
07/2900001@Limit2015201384478.9-3.19%423
07/2800001@Limit207180-1183181.5-3.09%242
07/27200-21@Limit2049850-3684284.1-1.98%453
07/243800-383@Limit20.0118501387885.8-4.35%512
07/2313403341@Limit20.13461470-10186589.7-9.21%972
07/2207078@Limit20.03000096698.8-4.08%304
07/2100001@Limit2000009661033.00%249
07/2000001@Limit200000966100-5.21%270
07/17100-11@Limit200000966105.5-8.66%370
07/1601012@Limit20.010000966115.56.45%674
日期 當沖成交張數 買進成交金額 賣出成交金額 現股當沖率(%) 平均盈虧
08/2651863,050,50063,760,00030.931369.69
08/251,410161,937,000162,044,00061.9575.89
08/2466272,223,50072,789,50048.13854.98
08/2187496,870,00096,851,50053.47-21.17
08/2000000
08/1912511,967,80011,979,70048.995.2
08/1830329,220,00029,301,40062.99268.65
08/1721821,434,50021,468,10048.38154.13
08/1433133,766,00033,765,10056.58-2.72
08/1320520,710,00020,776,70048.85325.37
08/1235535,930,80036,067,10047.14383.94
08/111,093119,691,500120,167,00052.24435.04
08/1089688,110,10088,755,30045.6720.09
08/0771967,140,20067,575,60047.32605.56
08/061109,052,3009,349,60024.962702.73
08/05987,774,0007,793,50037.22198.98
08/04756,030,8006,042,40036.4154.67
08/0321316,871,80017,036,20047.21771.83
07/3115111,469,60011,496,80044.85180.13
07/3017012,793,30012,884,10047.01534.12
07/2917413,566,30013,617,00041.15291.38
07/28816,649,6006,675,30033.43317.28
07/2723820,715,40020,717,90052.5210.5
07/2420918,363,70018,448,00040.81403.35
07/2341438,304,50038,365,40042.61147.1
07/0771778,585,00078,849,50030.8368.9
07/06121,218,0001,218,0003.20
07/034370,400370,4001.10
07/0224119,865,40019,899,30026.6140.66
07/0139528,770,40028,795,90034.8364.56
共信-KY動物新藥病例研究發表傳喜訊 規劃將臨床研究擴展至澳洲Anue鉅亨-2026/07/27
共信-KY脂肪消融產品獲歐洲專利 攻全球百億美元醫美商機Anue鉅亨-2026/06/30
共信-KY 相關文章
共信-KY 相關影音